002462 Cachet PharmaceuticalWatchlist
Cachet Pharmaceutical News
Jiashitang (002462): Performance is in line with expectations, and the shareholding ratio of majority shareholders has increased dramatically
Jiashitang (002462): rapid growth of equipment Wholesale Business and remarkable improvement in operating efficiency
Jiashitang (002462): good performance and rapid development of outport business
Ka Shitang (002462): the performance is in line with the expected outport business to maintain rapid development.
Jiashitang (002462): smooth transition of business in Beijing area and continuous development of business in other areas.
Jiashitang (002462) Quarterly Report Review: Third-quarter Growth Meets Expectations, Steady Progress in Distribution of Consumables
Jiashitang (002462) Quarterly Report Review: Performance Meets Expectations and Actively Promotes Foreign Port Business Layout
Jiashitang (002462): the performance is in line with the expected development momentum of the equipment business.
Jiashitang (002462) Quarterly Report Review: The performance growth rate in the 3rd quarter was good, and the company's value was clearly underestimated
In-depth study of Jiashitang (002462): The prospects for medical reform to promote the integration of pharmaceutical wholesale consumables are clear
Jiashitang (002462) Interim Report: Performance maintained rapid growth in the first half of the year and continued to expand foreign port business
Jiashitang (002462): Second quarter results accelerated epitaxial expansion and integration showed results
Jiashitang (002462) Semi-Annual Report Review: Leading Equipment Distribution, Continued Steady Growth in Performance
Jiashitang (002462) Semi-Annual Report Review: The growth rate is in line with expectations, and the Beijing region has performed well
Commentary on the semi-annual report of Jiashitang (002462): Performance is gradually picking up, and the national layout is progressing steadily
Jiashitang (002462) Semi-Annual Report Review: The Beijing Region Benefits Sunshine Procurement's Steady Expansion Across the Country
Jiashitang (002462) Interim Report: Growth accelerated in the second quarter and the performance of students within half a year was good
Jiashitang (002462) Semi-Annual Report Review: Pharmaceutical Device Dual Wheel Drive Performance Is Growing Rapidly
Jiashitang (002462) Annual Report Review: High Revenue Growth Is Optimistic About National Expansion
Commentary on the 2017 Report and 2018 Quarterly Report of Carshitang (002462): Performance is basically in line with expectations, and outreach expansion continues